Afamelanotide in fair-skinned Parkinson’s patients
June 17, 2024 20:39 ET
|
Clinuvel Pharmaceuticals Limited
CLINUVEL has launch a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease in fair-skinned patients.
CLINUVEL Expands Pharmaceutical Portfolio
November 07, 2021 23:03 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its pharmaceutical development portfolio with NEURACTHEL®, novel formulations of the melanocortin adrenocorticotropic...